159 related articles for article (PubMed ID: 27173669)
41. Intra-arterial nimodipine to treat symptomatic cerebral vasospasm following traumatic subarachnoid haemorrhage. Technical case report.
Conti A; Angileri FF; Longo M; Pitrone A; Granata F; La Rosa G
Acta Neurochir (Wien); 2008 Nov; 150(11):1197-202; discussion 1202. PubMed ID: 18958388
[TBL] [Abstract][Full Text] [Related]
42. Effect of treatment modality and cerebral vasospasm agent on patient outcomes after aneurysmal subarachnoid hemorrhage in the elderly aged 75 years and older.
Ido K; Kurogi R; Kurogi A; Nishimura K; Arimura K; Nishimura A; Ren N; Kada A; Matsuo R; Onozuka D; Hagihara A; Takagishi S; Yamagami K; Takegami M; Nohara Y; Nakashima N; Kamouchi M; Date I; Kitazono T; Iihara K;
PLoS One; 2020; 15(4):e0230953. PubMed ID: 32271814
[TBL] [Abstract][Full Text] [Related]
43. Statin-treated patients with aneurysmal subarachnoid haemorrhage: a meta-analysis.
Zhu RL; Chen ZJ; Li S; Lu XC; Tang LJ; Huang BS; Yu W; Wang X; Qian TD; Li LX
Eur Rev Med Pharmacol Sci; 2016 May; 20(10):2090-8. PubMed ID: 27249609
[TBL] [Abstract][Full Text] [Related]
44. Current advances in the diagnosis of vasospasm.
Munch E; Vajkoczy P
Neurol Res; 2006 Oct; 28(7):703-12. PubMed ID: 17164033
[TBL] [Abstract][Full Text] [Related]
45. Treatment of cerebral vasospasm after subarachnoid hemorrhage--a review.
Wu CT; Wong CS; Yeh CC; Borel CO
Acta Anaesthesiol Taiwan; 2004 Dec; 42(4):215-22. PubMed ID: 15679131
[TBL] [Abstract][Full Text] [Related]
46. Blood pressure changes after aneurysmal subarachnoid hemorrhage and their relationship to cerebral vasospasm and clinical outcome.
Faust K; Horn P; Schneider UC; Vajkoczy P
Clin Neurol Neurosurg; 2014 Oct; 125():36-40. PubMed ID: 25083804
[TBL] [Abstract][Full Text] [Related]
47. The impact of hormonal dynamics and serum sodium fluctuations on symptomatic vasospasm after subarachnoid hemorrhage.
Harada T; Uozumi Y; Fukuoka H; Miyake S; Yamamoto D; Okamura Y; Ishii T; Tatsumi S; Mizobe T; Aihara H; Tanaka K; Kohmura E; Sasayama T;
J Clin Neurosci; 2022 Sep; 103():131-140. PubMed ID: 35872447
[TBL] [Abstract][Full Text] [Related]
48. Clinical Course and Monitoring Parameters After Continuous Interventional Intra-Arterial Treatment in Patients with Refractory Cerebral Vasospasm.
von der Brelie C; Doukas A; Stopfer A; Larsen N; Mehdorn M; Synowitz M; Jansen O
World Neurosurg; 2017 Apr; 100():504-513. PubMed ID: 28131927
[TBL] [Abstract][Full Text] [Related]
49. Platelet-derived growth factor-induced severe and chronic vasoconstriction of cerebral arteries: proposed growth factor explanation of cerebral vasospasm.
Zhang ZW; Yanamoto H; Nagata I; Miyamoto S; Nakajo Y; Xue JH; Iihara K; Kikuchi H
Neurosurgery; 2010 Apr; 66(4):728-35; discussion 735. PubMed ID: 20305494
[TBL] [Abstract][Full Text] [Related]
50. Novel vasodilatory effect of intracisternal injection of magnesium sulfate solution on spastic cerebral arteries in the canine two-hemorrhage model of subarachnoid hemorrhage.
Mori K; Miyazaki M; Hara Y; Aiko Y; Yamamoto T; Nakao Y
J Neurosurg; 2009 Jan; 110(1):73-8. PubMed ID: 18834261
[TBL] [Abstract][Full Text] [Related]
51. Haemodynamic augmentation in the treatment of vasospasm in aneurysmal subarachnoid hemorrhage.
Gura M; Elmaci I; Cerci A; Sagiroglu E; Coskun KK
Turk Neurosurg; 2012; 22(4):435-40. PubMed ID: 22843460
[TBL] [Abstract][Full Text] [Related]
52. Hyponatremia in Traumatic Brain Injury: A Practical Management Protocol.
Rajagopal R; Swaminathan G; Nair S; Joseph M
World Neurosurg; 2017 Dec; 108():529-533. PubMed ID: 28899834
[TBL] [Abstract][Full Text] [Related]
53. [Therapeutic effect of a mineralocorticoid in patients with hyponatremia of central origin].
Morinaga K; Hayashi S; Matsumoto Y; Omiya N; Mikami J; Sato H; Inoue Y; Okawara S; Ishimaru K
No To Shinkei; 1995 Jul; 47(7):671-4. PubMed ID: 7612384
[TBL] [Abstract][Full Text] [Related]
54. Effects of nimodipine on cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage treated by endovascular coiling.
Mijailovic M; Lukic S; Laudanovic D; Folic M; Folic N; Jankovic S
Adv Clin Exp Med; 2013; 22(1):101-9. PubMed ID: 23468268
[TBL] [Abstract][Full Text] [Related]
55. Magnesium sulfate therapy after aneurysmal subarachnoid hemorrhage.
Veyna RS; Seyfried D; Burke DG; Zimmerman C; Mlynarek M; Nichols V; Marrocco A; Thomas AJ; Mitsias PD; Malik GM
J Neurosurg; 2002 Mar; 96(3):510-4. PubMed ID: 11883835
[TBL] [Abstract][Full Text] [Related]
56. [Guidelines for the treatment of aneurysmal subarachnoid hemorrhage. A consensus conference].
Dorfman BS; Previgliano IJ
Medicina (B Aires); 2000; 60(3):370-4. PubMed ID: 11050821
[TBL] [Abstract][Full Text] [Related]
57. Emergence of a R-type Ca2+ channel (CaV 2.3) contributes to cerebral artery constriction after subarachnoid hemorrhage.
Ishiguro M; Wellman TL; Honda A; Russell SR; Tranmer BI; Wellman GC
Circ Res; 2005 Mar; 96(4):419-26. PubMed ID: 15692089
[TBL] [Abstract][Full Text] [Related]
58. Effects of thrombin inhibitor on thrombin-related signal transduction and cerebral vasospasm in the rabbit subarachnoid hemorrhage model.
Tsurutani H; Ohkuma H; Suzuki S
Stroke; 2003 Jun; 34(6):1497-500. PubMed ID: 12764230
[TBL] [Abstract][Full Text] [Related]
59. Relationship of hypotension and cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage.
Tabuchi S; Hirano N; Tanabe M; Kurosaki M; Okamoto H; Kamitani H; Yokota M; Watanabe T
Neurol Res; 2006 Mar; 28(2):196-9. PubMed ID: 16551440
[TBL] [Abstract][Full Text] [Related]
60. Arctigenin, a Potent Ingredient of Arctium lappa L., Induces Endothelial Nitric Oxide Synthase and Attenuates Subarachnoid Hemorrhage-Induced Vasospasm through PI3K/Akt Pathway in a Rat Model.
Chang CZ; Wu SC; Chang CM; Lin CL; Kwan AL
Biomed Res Int; 2015; 2015():490209. PubMed ID: 26539501
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
